Dolutegravir Sodium CAS NO1051375-19-9

Dolutegravir Sodium CAS NO1051375-19-9

CAS NO: 1051375-19-9
Molecular Formula: C20H18F2N3NaO5
Molecular Weight: 441.36
EINECS NO: 812-620-6
MDL NO: MFCD28405599
Chat Now

Product Details

Product Description:

Product Name: Dolutegravir Sodium CAS NO:1051375-19-9



Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate;


(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino-[2,1-b][1,3]oxazine-9-carboxamide sodium salt;


Chemical & Physical Properties:

Appearance :pale yellow powder

Assay :≥99.0%



Dolutegravir Sodium is a second-generation HIV-1 integrase chain transfer inhibitor. Dolutegravir Sodium is currently in a phase III clinical trial for the treatment of HIV infection. It has been shown that Dolutegravir Sodium can effectively inhibit HIV replication in cells infected with the inactivated PHIV lentiviral vector, such as peripheral blood mononuclear cells (PBMC), MT-4 cells and CIP4 cells.



If you are interested in our products or have any questions, please feel free to contact us!




Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.



Hot Tags: dolutegravir sodium cas no1051375-19-9, manufacturers, suppliers, factory, buy, in stock, 9-Amino Minocycline Sulphate, Oseltamivir, 5-(2-bromoacetyl)-2-hydroxybenzaldehyde, Intermediates, CAS NO:1021298-67-8, CAS 13073-25-1


You Might Also Like